Chukwunonso Nwabufo

7PUBLICATIONS
7CO-AUTHORS
PharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Neurology and neuromuscular diseasesBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 29, 2024
Uncovering the Impact of COVID-19 Mediated Bidirectional Dysregulation of CYP3A4 on Systemic and Pulmonary Drug Concentrations Using Physiologically Based Pharmacokinetic Modeling.

Chukwunonso K Nwabufo

|May 31, 2024
COVID-19 severity gradient differentially dysregulates clinically relevant drug processing genes in nasopharyngeal swab samples.

Chukwunonso K Nwabufo, Jessica Luc, Allison McGeer

|Aug 18, 2023
Mirvetuximab soravtansine in ovarian cancer therapy: expert opinion on pharmacological considerations.

Chukwunonso K Nwabufo

|Jul 13, 2022
Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson's disease.

Chukwunonso K Nwabufo, Omozojie P Aigbogun

|Apr 06, 2021
Pharmacogenomics in the era of next generation sequencing - from byte to bedside.

Laura E Russell, Yitian Zhou, Ahmed A Almousa

|May 28, 2020
Advances in the study of drug metabolism - symposium report of the 12th Meeting of the International Society for the Study of Xenobiotics (ISSX).

Laura E Russell, Mary Alexandra Schleiff, Eric Gonzalez

Pageof 2

Frequent Collaborators

1 joint publications

Anas El-Aneed

1 joint publications

Ed S Krol

1 joint publications

Laura E Russell

1 joint publications

Mary Alexandra Schleiff